Posted by Michael Wonder on 07 Jul 2020
U.S. commits $2 billion for COVID-19 vaccine, drug supplies
7 July 2020 - Novavax, Regeneron are awarded government funding.
The federal government awarded $2 billion to two drugmakers to support development and manufacturing of an experimental drug and a potential vaccine against COVID-19.
Novavax said it would receive $1.6 billion from the federal government to fund clinical studies of its experimental coronavirus vaccine and establish large-scale manufacturing of doses. With the funding, Novavax said it would deliver 100 million doses of its vaccine for use in the U.S., possibly by the end of this year.
